MST-188 (Purified poloxamer 188)

poloxamer 188 · Mast Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MST-188 (Purified poloxamer 188), covering 2016-10-28 to 2016-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Repeat Administration of Purified Poloxamer 188 [Phase 3]